Tenax Therapeutics (TENX) Short-term Investments: 2015-2017
Historic Short-term Investments for Tenax Therapeutics (TENX) over the last 2 years, with Sep 2017 value amounting to $6.8 million.
- Tenax Therapeutics' Short-term Investments rose 0.22% to $6.8 million in Q3 2017 from the same period last year, while for Sep 2017 it was $6.8 million, marking a year-over-year increase of 0.22%. This contributed to the annual value of $3.3 million for FY2016, which is N/A change from last year.
- According to the latest figures from Q3 2017, Tenax Therapeutics' Short-term Investments is $6.8 million, which was up 3.17% from $6.6 million recorded in Q2 2017.
- Over the past 5 years, Tenax Therapeutics' Short-term Investments peaked at $16.5 million during Q4 2015, and registered a low of $3.3 million during Q4 2016.
- For the 3-year period, Tenax Therapeutics' Short-term Investments averaged around $7.6 million, with its median value being $6.8 million (2016).
- Per our database at Business Quant, Tenax Therapeutics' Short-term Investments tumbled by 80.13% in 2016 and then rose by 0.22% in 2017.
- Over the past 3 years, Tenax Therapeutics' Short-term Investments (Quarterly) stood at $16.5 million in 2015, then plummeted by 80.13% to $3.3 million in 2016, then increased by 0.22% to $6.8 million in 2017.
- Its Short-term Investments was $6.8 million in Q3 2017, compared to $6.6 million in Q2 2017 and $5.5 million in Q1 2017.